Quarterly Transactions Made in Eagle Pharmaceuticals, Inc. (EGRX)
This table provides information about the institutional ownership of Eagle Pharmaceuticals, Inc. (EGRX). The information is specifically focused on institutions that hold shares of EAGLE PHARMACEUTICALS, INC..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 454,182 | 932,324 | 1,386,506 | 783,186 | 78,774 | 861,960 | 524,546 | |
| Q4 2021 | 323,286 | 420,180 | 743,466 | 786,149 | 514,477 | 1,300,626 | -557,160 | |
| Q1 2022 | 613,658 | 385,039 | 998,697 | 633,980 | 467,044 | 1,101,024 | -102,327 | |
| Q2 2022 | 989,145 | 414,981 | 1,404,126 | 792,460 | 79,318 | 871,778 | 532,348 | |
| Q3 2022 | 1,138,715 | 209,263 | 1,347,978 | 953,215 | 37,952 | 991,167 | 356,811 | |
| Q4 2022 | 592,257 | 990,526 | 1,582,783 | 747,241 | 0 | 747,241 | 835,542 | |
| Q1 2023 | 1,627,843 | 268,067 | 1,895,910 | 1,179,370 | 0 | 1,179,370 | 716,540 | |
| Q2 2023 | 1,543,049 | 150,891 | 1,693,940 | 1,982,091 | 0 | 1,982,091 | -288,151 | |
| Q3 2023 | 736,719 | 400,737 | 1,137,456 | 994,053 | 12,000 | 1,006,053 | 131,403 | |
| Q4 2023 | 1,937,048 | 842,132 | 2,779,180 | 1,566,131 | 0 | 1,566,131 | 1,213,049 | |
| Q1 2024 | 1,348,317 | 2,590,627 | 3,938,944 | 1,293,050 | 0 | 1,293,050 | 2,645,894 | |
| Q2 2024 | 1,780,144 | 441,558 | 2,221,702 | 2,121,881 | 0 | 2,121,881 | 99,821 | |
| Q3 2024 | 537,718 | 271,998 | 809,716 | 1,105,251 | 0 | 1,105,251 | -295,535 | |